Panitumumab–FOLFOX4 Treatment and RAS Mutations in Colorectal Cancer-Reference-Cited by-同舟云学术

Panitumumab–FOLFOX4 Treatment and RAS Mutations in Colorectal Cancer

Published:2013-09-12 Issue:11 Volume:369 Page:1023-1034
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Douillard Jean-Yves,Oliner Kelly S.,Siena Salvatore,Tabernero Josep,Burkes Ronald,Barugel Mario,Humblet Yves,Bodoky Gyorgy,Cunningham David,Jassem Jacek,Rivera Fernando,Kocákova Ilona,Ruff Paul,Błasińska-Morawiec Maria,Šmakal Martin,Canon Jean Luc,Rother Mark,Williams Richard,Rong Alan,Wiezorek Jeffrey,Sidhu Roger,Patterson Scott D.

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMoa1305275

Cited by 1948 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug recommendation ranking for personalized medicine using outcomes of retrospective cancer patients;Expert Systems with Applications;2024-12

2. Successful cetuximab rechallenge in metastatic colorectal cancer: A case report;World Journal of Clinical Oncology;2024-09-24

3. Association between sidedness and survival among chemotherapy refractory metastatic colorectal cancer patients treated with trifluridine/tipiracil or regorafenib;The Oncologist;2024-09-07

4. Impact of primary tumor sidedness and sex on prognosis and anti-epidermal growth factor receptor antibody efficacy in BRAF-mutant metastatic colorectal cancer: a pooled analysis of AIO studies FIRE-1, CIOX, FIRE-3, XELAVIRI, and VOLFI;ESMO Open;2024-09

5. Targeting the RAS upstream and downstream signaling pathway for cancer treatment;European Journal of Pharmacology;2024-09